U.S. federal trademark · Serial No. 90468677
Development of pharmaceutical preparations for the treatment of cancer; development of platform technology, namely, immunotherapy platforms for manufacturing cancer therapeutics; scientific research services, namely, antibody engineering for analytical and clinical purposes
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.